The EMA perspective on drug approval process in the era of precision medicine

Bookmark and Share
Published: 21 Feb 2018
Views: 6076
Jorge Camarero - Spanish Agency of Medicines and Medical Services, Spain

Jorge Camarero presents at ecancer's Milan Summit on Precision Medicine 2018 about regulatory challenges in the era or personalised medicine and the European Medicines Agency perspective on the drug approval process.

The webcast has been supported by an unrestricted educational grant from Roche Foundation Medicine